Nasal polyposis, De Corso (Gemelli Polyclinic): “Very encouraging results of mepolizumab in serious patients”

On the occasion of the Gsk symposium “New frontiers in CRSwNP: precision therapy with mepolizumab”, dedicated to chronic rhinosinusitis with nasal polyposis and its new treatment options, organized during the 109th National Congress of Sio, the Italian Society of otolaryngology and head and neck surgery, taking place from 24 to 27 May 2023 in Milan, Dr. Eugenio De Corso, otolaryngologist at the Gemelli Polyclinic in Rome, spoke.